Bolt Biotherapeutics, Inc. (BOLT) Return on equity 2021–2025
Bolt Biotherapeutics, Inc. (BOLT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-125.9%FY2025 · since FY2021: -39.4% → -125.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -125.9% | -15.6 pp |
| FY2024 | -110.4% | -49.0 pp |
| FY2023 | -61.4% | -10.0 pp |
| FY2022 | -51.4% | -11.9 pp |
| FY2021 | -39.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice